A 1q21 deletion

1. Blatt J., Deal A.M., Mesibov G. Autism in children and adolescents with cancer. Pediatr Blood Cancer 2010;54(1):144–7.

2. Bernier R., Steinman K.J., Reilly B. et al. Clinical phenotype of the recurrent 1q21.1 copy-number variant. Genet Med 2016;18(4):341–9.

3. Brunetti-Pierri N., Berg J.S., Scaglia F. et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 2008;40(12):1466–71.

4. Bosse K.R., Maris J.M. Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations. Cancer 2016;122(1):20–33.

5. Diskin S.J., Hou C., Glessner J.T. et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature 2009;459:987–91.

6. Качанов Д.Ю., Шаманская Т.В., Шевцов Д.В. и др. Генетическая предрасположенность к нейробластоме у детей: собственные данные и обзор литературы. Онкопедиатрия 2016;3(4):277–87. [Kachanov D.Yu., Shamanskaya T.V., Shevtsov D.V. et al. Genetic predisposition to neuroblastoma in children: own data and literature review. Onkopediatriya = Oncopediatrics 2016;3(4):277–87. (In Russ.)].